Dose
Vendor:
First CVE: Feb 16, 2023 · Active for 3 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
4.3
Avg CVSS
Higher Avg CVSS than 3% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Dose over time
Volume of CVEsAvg CVSS Base Score
First CVE
Feb 16, 2023
3 years ago
Most Recent CVE
Feb 16, 2023
1,258 days ago
CVE Severity & Scoring
Dose1 CVEs
100%
All CVEs353,173 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low1 (100.0%)
High0 (0.0%)
None0 (0.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2022-38731MEDIUM Qaelum DOSE 18.08 through 21.1 before 21.2 allows Directory Traversal via the loadimages name parameter. It allows a user to specify an arbitrary location on the server's filesyste | Feb 16, 2023 | 4.3 | 17 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Dose
Top CWEs
Versions
No cataloged versions.